Ryan Terlecki, MD
Urology · Winston Salem, NCNPI 1225235021
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 98.8% of it on its own, with 8 other manufacturers making up the rest. Among urology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 407 payments — averaging $537.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$216K
- SWAN Valley Medical Incorporated$1K
- Procept Biorobotics Corporation$1K
- Valencia Technologies Corporation$132
- Ambu Inc.$118
- Astellas Pharma US Inc$115
- plus $197 from 3 others
Across 19 payments — averaging $1979.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$38K
What the payments were for
- Consulting fees$63,25029%
- Speaking & faculty fees$123,50056%
- Grants$3,5002%
- Travel & lodging$17,9208%
- Food & beverage$10,5995%
- Education$1680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 388 | $216,277 |
| SWAN Valley Medical Incorporated | 2 | $1,082 |
| Procept Biorobotics Corporation | 7 | $1,016 |
| Valencia Technologies Corporation | 1 | $132 |
| Ambu Inc. | 1 | $118 |
| Astellas Pharma US Inc | 2 | $115 |
| C. R. Bard, Inc. & Subsidiaries | 4 | $114 |
| Blue Earth Diagnostics | 1 | $68 |
| Coloplast | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ERECTILE DYSFUNCTION$48,978
- AMS$40,611
- AdVance XP$27,070
- GENERAL - THERAPIES$21,545
- TACTRA$12,258
- AMS 700$2,572
- AMS 700 CXR RTE KIT$2,222
- ADVANCE$1,411
- AMS 800 Artificial Urinary Sphincter$1,269
- AquaBeam Robotic System$820
- GENERAL MALE SUI$229
- AMS AMBICOR$137
- eCoin Device Kit$132
- rezum Generator$123
- LithoVue$107
How this compares
$218,937 in reported general payments places this provider in the 95th percentile of 434 urology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 54 | $42,536 |
| Tamsulosin Hcl | 115 | $1,456 |
| Solifenacin Succinate | 25 | $778 |
| Testosterone Cypionate | 11 | $616 |
| Finasteride | 61 | $535 |
| Oxybutynin Chloride ErOxybutynin Chloride | 27 | $264 |
| Anastrozole | 13 | $112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $115 | $42,53654 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 434 urology providers in North Carolina.
Other urology in Winston Salem
- Soroush Rais-BahramiWinston Salem$66K
- Ethan MatzWinston Salem$62K
- Kyle ScarberryWinston Salem$57K
- Connor PolicastroWinston Salem$53K
- Colin KleinguetlWinston Salem$52K
- Anthony AtalaWinston Salem$26K
- Gopal BadlaniWinston Salem$25K
- Alejandro RodriguezWinston Salem$17K
- John SmithWinston Salem$17K
- Robert LippittSmithfield$11.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.